Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
topic_facet:"HIV Infections"
publishDate:"[2020 TO 2029]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22HIV+Infections%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=ritonavir&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22HIV+Infections%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=ritonavir&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22HIV+Infections%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=ritonavir&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (44)
1
A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA) : A Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine Once Daily Compared to Atazanavir and Ritonavir Plus Tenofovir/Emtricitabine Once Daily in HIV-1 Infected Antiretroviral Therapy Naïve Women
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study : Double-blind, Randomized, Dose Optimization Trial of Three Doses of Tipranavir Boosted With Low Dose Ritonavir (TPV/RTV) in Multiple Antiretroviral Drug-experienced Subjects
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
3
HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label : A Randomized Comparative Phase II Trial Evaluating the Capacity of the Dual Combination Doravirine/Raltegravir to Maintain Virological Success in HIV-1 Infected Patients With an HIV-RNA Plasma Viremia Below 50 Copies/mL Under a Current Antiretroviral Regimen
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
4
Dual Therapy With Boosted Darunavir + Dolutegravir : A Prosp., Multic., Randomized, Open-label Trial to Assess the Safety, Tolerability and Efficacy of Dual Therapy With Boosted Darunavir + Dolutegravir When Switching From SOC ART in HIV-patients With Sustained Virological Suppr.
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
5
Adipose Tissue After Switch to Doravirine : A Pathogenesis Pilot Study to Evaluate the Impact of Switching to Tenofovir/Lamivudine/Doravirine on Adipose Tissue (AT) Morphology and Functions in Suppressed Patients With Weight Gain on an INSTI-based Regimen
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
6
Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission : Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof of Concept Study
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
7
Drug-drug Interaction (DDI) Study of GSK3640254 With Darunavir/Ritonavir (DRV/RTV) and Etravirine (ETR) : Open-Label, Single-Sequence Study to Evaluate the Effects of Darunavir/Ritonavir and/or Etravirine on the Pharmacokinetics of GSK3640254 and the Effects of GSK3640254 on the Pharmacokinetics of Darunavir/Ritonavir and/or Etravirine in Heathy Adults
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
8
Body Composition Sub-study of the D2EFT Trial : Body Composition Sub-study of the D2EFT Trial
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
9
Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection : A Randomized Study to Compare the Efficacy of Vorinostat/Hydroxychloroquine/Maraviroc (VHM) in Controlling HIV After Treatment Interruption in Subjects Who Initiated ART During Acute HIV Infection
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
10
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease : A Phase 4 Study of the Effect on Immune Reconstitution of a Lopinavir/Ritonavir-Based Versus an Efavirenz-based HAART (Highly Active Antiretroviral Therapy) Regimen in Antiretroviral-Naïve Subjects With Advanced HIV Disease
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: HIV Infections
Filter aufheben
Erscheinungsjahr: 2020-2029
Medienart
44
Aufsätze
44
E-Artikel
44
E-Ressourcen
Zeitschriftentitel
44
ClinicalTrials.gov
Thema
44
610
HIV Infections
40
Study Type: Interventional
31
Recruitment Status: Completed
18
Acquired Immunodeficiency Syndrome
14
Medical Condition: HIV Infections
10
Phase: Phase 2
9
Phase: Phase 3
8
Phase: Phase 4
6
Communicable Diseases
6
Recruitment Status: Recruiting
5
Immunologic Deficiency Syndromes
5
Phase: Phase 1
4
Infection
4
Study Type: Observational
3
Infections
3
Medical Condition: HIV Infection
3
Phase: Phase 1, Phase 2
3
Recruitment Status: Active, not recruiting
3
Recruitment Status: Terminated
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2020-
1
2024
11
2023
5
2022
9
2021
18
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
44
Englisch
Haven't found what you're looking for?
Wird geladen...